Mankind Pharma
- All
- News
- Videos
-
Mankind MD Reveals Donating Rs 250 Crore Towards Covid Relief After Miscalculation Of Zero
"What we had pledged, we had to donate 10x more. So we ended up giving around Rs 250 crore at that time," the Managing Director of Mankind Pharma said.
-
Income Tax Raids At Mankind Pharma Premises In Delhi Over Alleged Tax Evasion
The Income Tax department today conducted searches on the premises of Mankind Pharma over allegations of tax evasion, official sources said.
-
Mankind Pharma IPO: 5 Things To Know
The long-awaited Mankind Pharma IPO is opening soon. Find out key details inside.
-
Mankind Pharma IPO (Public Offer): Price Band Set At 1,026 To 1,080 Rupees A Share
Pharmaceutical company Mankind Pharma Ltd has set a price band of 1,026 rupees to 1,080 rupees per share for its initial public offering (IPO).
-
Mankind Pharma Share Sale: IPO (Public Offer) To Open On April 25
The initial share sale of drug maker Mankind Pharma will open for public subscription on April 25.
-
Mankind Pharma Files For Initial Public Offering
Mankind Pharma has filed preliminary papers with the markets regulator Sebi to raise funds through an Initial Public Offering (IPO).
-
Mankind Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG
Drug firm Mankind Pharma today said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19.
-
Competition Watchdog Approves Mankind Pharma's 11% Stake Sale to PE Investors
Approving the deal, the fair trade regulator said the transaction is not likely to have any appreciable adverse effect on competition in India.
-
Mankind Pharma Looks to Spend Rs 500 Cr to Buy Rivals
Mankind sells more than a thousand products in India across 14 therapeutic areas ranging from pain and allergy to cardiology, neurology, diabetology, and women's health.
-
Mankind Pharma Setting Up Rs 100 Crore Facility in Rajasthan
Mankind Pharma is investing around Rs 100 crore to set up an active pharmaceutical ingredients (API) facility in Rajasthan, which is expected to go on stream by the end of the year.
-
Mankind MD Reveals Donating Rs 250 Crore Towards Covid Relief After Miscalculation Of Zero
"What we had pledged, we had to donate 10x more. So we ended up giving around Rs 250 crore at that time," the Managing Director of Mankind Pharma said.
-
Income Tax Raids At Mankind Pharma Premises In Delhi Over Alleged Tax Evasion
The Income Tax department today conducted searches on the premises of Mankind Pharma over allegations of tax evasion, official sources said.
-
Mankind Pharma IPO: 5 Things To Know
The long-awaited Mankind Pharma IPO is opening soon. Find out key details inside.
-
Mankind Pharma IPO (Public Offer): Price Band Set At 1,026 To 1,080 Rupees A Share
Pharmaceutical company Mankind Pharma Ltd has set a price band of 1,026 rupees to 1,080 rupees per share for its initial public offering (IPO).
-
Mankind Pharma Share Sale: IPO (Public Offer) To Open On April 25
The initial share sale of drug maker Mankind Pharma will open for public subscription on April 25.
-
Mankind Pharma Files For Initial Public Offering
Mankind Pharma has filed preliminary papers with the markets regulator Sebi to raise funds through an Initial Public Offering (IPO).
-
Mankind Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG
Drug firm Mankind Pharma today said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19.
-
Competition Watchdog Approves Mankind Pharma's 11% Stake Sale to PE Investors
Approving the deal, the fair trade regulator said the transaction is not likely to have any appreciable adverse effect on competition in India.
-
Mankind Pharma Looks to Spend Rs 500 Cr to Buy Rivals
Mankind sells more than a thousand products in India across 14 therapeutic areas ranging from pain and allergy to cardiology, neurology, diabetology, and women's health.
-
Mankind Pharma Setting Up Rs 100 Crore Facility in Rajasthan
Mankind Pharma is investing around Rs 100 crore to set up an active pharmaceutical ingredients (API) facility in Rajasthan, which is expected to go on stream by the end of the year.
